Financial Ratios IRLAB Therapeutics AB

Stocks

IRLAB A

SE0012675361

Pharmaceuticals

Market Closed - Nasdaq Stockholm 12:00:00 2026-09-04 EDT			5-day change	1st Jan Change
1.710 ^SEK	-0.70%		-4.36%	-13.20%

09-03	Irlab CEO Kristina Torfgaard to step down in 2027	FW
09-03	Irlab CEO Kristina Torfgaard wants to step down	FW

03bc853b9c4051bcc.UF8_LZWQDkbp_ZHsbFbFkeszUZkCavUJiKqlo3Hy4ag.GDRMAMX9aymEuNzUXhWv45hlN_pwErNjzpjO-xjEiMU5K3Ff9KN5HKCHwA

Published financial data: IRLAB THERAPEUTICS AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (SEK)	2022 (SEK)	2023 (SEK)	2024 (SEK)	2025 (SEK)
Revenues	208M	61.14M	5.68M	94.63M	57.46M
Other Revenues, Total	-	-	-	-	-
Total Revenues	208M	61.14M	5.68M	94.63M	57.46M
Cost of Goods Sold, Total	81.74M	126M	128M	136M	99.38M
Gross Profit	126M	-64.77M	-123M	-41.66M	-41.91M
Selling General & Admin Expenses, Total	31.02M	42.48M	53.08M	46.18M	46.12M
Depreciation & Amortization - (IS)	3.47M	4.78M	4.32M	4.58M	4.32M
Other Operating Expenses	38.97M	-27K	-42K	-19.46M	-5.33M
Other Operating Expenses, Total	73.47M	47.23M	57.36M	31.31M	45.1M
Operating Income	52.58M	-112M	-180M	-72.97M	-87.02M
Interest Expense, Total	-370K	-297K	-199K	-10.48M	-17.99M
Interest And Investment Income	1K	-	3.12M	2.46M	1.38M
Net Interest Expenses	-369K	-297K	2.93M	-8.02M	-16.61M
Currency Exchange Gains (Loss)	-426K	-1.11M	-676K	-2.14M	-6.38M
Other Non Operating Income (Expenses)	-	-	1K	-	-1K
EBT, Excl. Unusual Items	51.78M	-113M	-178M	-83.13M	-110M
Asset Writedown	-	-	-	-	-
Insurance Settlements	-	-	-	-	-
EBT, Incl. Unusual Items	51.78M	-113M	-178M	-83.13M	-110M
Income Tax Expense	-	-	-	-	-
Earnings From Continuing Operations	51.78M	-113M	-178M	-83.13M	-110M
Net Income to Company	51.78M	-113M	-178M	-83.13M	-110M
Net Income - (IS)	51.78M	-113M	-178M	-83.13M	-110M
Net Income to Common Incl Extra Items	51.78M	-113M	-178M	-83.13M	-110M
Net Income to Common Excl. Extra Items	51.78M	-113M	-178M	-83.13M	-110M
Per Share Items
Net EPS - Basic	1	-2.19	-3.43	-1.6	-1.64
Basic EPS - Continuing Operations	1	-2.19	-3.43	-1.6	-1.64
Basic Weighted Average Shares Outstanding	51.75M	51.83M	51.87M	51.87M	67M
Net EPS - Diluted	1	-2.19	-3.43	-1.6	-1.64
Diluted EPS - Continuing Operations	1	-2.19	-3.43	-1.6	-1.64
Diluted Weighted Average Shares Outstanding	51.75M	51.83M	51.87M	51.87M	67M
Normalized Basic EPS	0.63	-1.37	-2.14	-1	-1.03
Normalized Diluted EPS	0.63	-1.37	-2.14	-1	-1.03
Supplemental Items
EBITDA	53.07M	-111M	-179M	-72.08M	-86.17M
EBITA	52.58M	-112M	-180M	-72.97M	-87.02M
EBIT	52.58M	-112M	-180M	-72.97M	-87.02M
EBITDAR	53.26M	-	-	-	-
Total Revenues (As Reported)	208M	61.28M	5.72M	114M	62.8M
Effective Tax Rate - (Ratio)	-	-	-	-	-
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	32.36M	-70.88M	-111M	-51.96M	-68.76M
Interest on Long-Term Debt	367K	-	-	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	130M	146M	151M	164M	131M
Net Rental Expense, Total	187K	-	-	-	-
Imputed Operating Lease Interest Expense	116K	-	-	-	-
Imputed Operating Lease Depreciation	70.8K	-	-	-	-

Fiscal Period: December	2021 (SEK)	2022 (SEK)	2023 (SEK)	2024 (SEK)	2025 (SEK)
Assets
Cash And Equivalents	402M	253M	111M	66.92M	81.86M
Total Cash And Short Term Investments	402M	253M	111M	66.92M	81.86M
Accounts Receivable, Total	4.47M	3.32M	-	-	-
Other Receivables	6.27M	8.9M	9.17M	10.08M	3.32M
Total Receivables	10.74M	12.22M	9.17M	10.08M	3.32M
Prepaid Expenses	2.28M	3.34M	2.8M	2.2M	2.91M
Other Current Assets, Total	6.52M	346K	314K	367K	382K
Total Current Assets	421M	269M	124M	79.56M	88.47M
Gross Property Plant And Equipment	16.71M	20.09M	23.07M	30.77M	30.77M
Accumulated Depreciation	-8.36M	-12.08M	-16.4M	-20.98M	-25.3M
Net Property Plant And Equipment	8.35M	8.01M	6.67M	9.79M	5.47M
Other Intangibles, Total	42.4M	46.86M	46.86M	46.86M	46.86M
Deferred Charges Long-Term	259K	-	-	-	-
Other Long-Term Assets, Total	-1K	-1K	-	-1K	1K
Total Assets	472M	324M	177M	136M	141M
Liabilities
Accounts Payable, Total	12.3M	10.03M	10.52M	9.94M	5.28M
Accrued Expenses, Total	5.84M	13.44M	14.91M	11.68M	14.08M
Short-term Borrowings	-	-	-	53.47M	26.42M
Current Portion of Leases	3.03M	3.6M	2.94M	3.42M	3.54M
Unearned Revenue Current, Total	42.58M	-	-	-	-
Other Current Liabilities	5.65M	5.28M	8.35M	21.54M	60.77M
Total Current Liabilities	69.4M	32.34M	36.73M	100M	110M
Long-Term Debt	-	-	24.51M	-	-
Long-Term Leases	3.57M	381K	115K	3.54M	-
Total Liabilities	72.97M	32.72M	61.36M	104M	110M
Common Stock, Total	1.04M	1.04M	1.04M	1.04M	1.7M
Additional Paid In Capital	685M	690M	690M	690M	800M
Retained Earnings	-287M	-400M	-575M	-659M	-771M
Comprehensive Income and Other	-	-	-	1K	-
Total Common Equity	399M	291M	116M	32.64M	30.72M
Total Equity	399M	291M	116M	32.64M	30.72M
Total Liabilities And Equity	472M	324M	177M	136M	141M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	51.75M	51.87M	51.87M	51.87M	84.94M
ECS Total Common Shares Outstanding	51.75M	-	51.87M	51.87M	84.94M
Book Value / Share	7.72	5.61	2.23	0.63	0.36
Tangible Book Value	357M	244M	68.9M	-14.23M	-16.14M
Tangible Book Value Per Share	6.9	4.7	1.33	-0.27	-0.19
Total Debt	6.6M	3.98M	27.57M	60.42M	29.95M
Net Debt	-395M	-249M	-83.74M	-6.5M	-51.91M
Debt Equivalent Oper. Leases	1.5M	-	-	-	-
Account Code - Inventory Valuation	3	-	3	3	3
Machinery, Total	3.65M	6.53M	6.82M	7.02M	-
Full Time Employees	27	-	34	31	31

Fiscal Period: December	2021 (SEK)	2022 (SEK)	2023 (SEK)	2024 (SEK)	2025 (SEK)
Net Income	51.78M	-113M	-178M	-83.13M	-110M
Depreciation & Amortization - CF	3.22M	3.72M	4.32M	4.58M	4.32M
Depreciation & Amortization, Total	3.22M	3.72M	4.32M	4.58M	4.32M
Amortization of Deferred Charges, Total - (CF)	259K	259K	-	-	-
Asset Writedown & Restructuring Costs	-	797K	-	-	-
Other Operating Activities, Total	39.09M	0	0	3.96M	8.73M
Change In Accounts Receivable	-12.81M	3.63M	3.63M	2.79M	5.68M
Change in Other Net Operating Assets	47.11M	-37.62M	5.04M	6.21M	36.06M
Cash from Operations	129M	-143M	-165M	-65.59M	-55.22M
Capital Expenditure	-708K	-2.88M	-293K	-199K	-
Sale (Purchase) of Intangible assets	-	-500K	-	-	-
Cash from Investing	-708K	-3.38M	-293K	-199K	-
Long-Term Debt Issued, Total	-	-	27.28M	25M	18.8M
Total Debt Issued	-	-	27.28M	25M	18.8M
Long-Term Debt Repaid, Total	-2.86M	-3.13M	-3.61M	-3.6M	-19.95M
Total Debt Repaid	-2.86M	-3.13M	-3.61M	-3.6M	-19.95M
Issuance of Common Stock	-	-	-	-	74.56M
Other Financing Activities, Total	-180K	-	-	-	-1K
Cash from Financing	-3.04M	-3.13M	23.68M	21.4M	73.4M
Foreign Exchange Rate Adjustments	-	-	-	-	-3.24M
Miscellaneous Cash Flow Adjustments	-	1K	-	1K	-
Net Change in Cash	125M	-149M	-141M	-44.39M	14.94M
Supplemental Items
Cash Interest Paid	796K	297K	199K	6.52M	12.5M
Levered Free Cash Flow	69.69M	-104M	-99.98M	-38.77M	-18.3M
Unlevered Free Cash Flow	69.92M	-103M	-99.86M	-32.22M	-7.06M
Change In Net Working Capital	-34.3M	33.98M	-8.67M	-9M	-43.01M
Net Debt Issued / Repaid	-2.86M	-3.13M	23.68M	21.4M	-1.15M

Fiscal Period: December	2021 (SEK)	2022 (SEK)	2023 (SEK)	2024 (SEK)	2025 (SEK)
Profitability
Return on Assets	7.8	-17.59	-44.96	-29.11	-39.27
Return on Total Capital	8.68	-19.98	-51.38	-38.59	-70.76
Return On Equity %	13.86	-32.86	-87.48	-112.03	-347.29
Return on Common Equity	13.86	-32.86	-87.48	-112.03	-347.29
Margin Analysis
Gross Profit Margin %	60.66	-105.94	-2.16K	-44.03	-72.94
SG&A Margin	14.93	69.49	934.87	48.8	80.25
EBITDA Margin %	25.54	-182	-3.16K	-76.17	-149.97
EBITA Margin %	25.3	-183.2	-3.17K	-77.11	-151.44
EBIT Margin %	25.3	-183.2	-3.17K	-77.11	-151.44
Income From Continuing Operations Margin %	24.92	-185.5	-3.13K	-87.85	-191.45
Net Income Margin %	24.92	-185.5	-3.13K	-87.85	-191.45
Net Avail. For Common Margin %	24.92	-185.5	-3.13K	-87.85	-191.45
Normalized Net Income Margin	15.58	-115.94	-1.96K	-54.91	-119.66
Levered Free Cash Flow Margin	33.54	-169.4	-1.76K	-40.97	-31.85
Unlevered Free Cash Flow Margin	33.65	-169.1	-1.76K	-34.05	-12.28
Asset Turnover
Asset Turnover	0.49	0.15	0.02	0.6	0.41
Fixed Assets Turnover	32.81	7.47	0.77	11.49	7.53
Receivables Turnover (Average Receivables)	-	15.69	-	-	-
Short Term Liquidity
Current Ratio	6.07	8.31	3.36	0.8	0.8
Quick Ratio	5.95	8.19	3.28	0.77	0.77
Operating Cash Flow to Current Liabilities	1.85	-4.41	-4.49	-0.66	-0.5
Days Sales Outstanding (Average Receivables)	-	23.26	-	-	-
Average Days Payable Outstanding	35.69	32.37	29.21	27.48	27.96
Long Term Solvency
Total Debt/Equity	1.65	1.37	23.81	185.14	97.51
Total Debt / Total Capital	1.63	1.35	19.23	64.93	49.37
LT Debt/Equity	0.89	0.13	21.27	10.83	-
Long-Term Debt / Total Capital	0.88	0.13	17.18	3.8	-
Total Liabilities / Total Assets	15.44	10.11	34.64	76.04	78.18
EBIT / Interest Expense	142.1	-377.11	-904.97	-6.96	-4.84
EBITDA / Interest Expense	150.79	-364.58	-883.29	-6.53	-4.6
(EBITDA - Capex) / Interest Expense	148.87	-374.26	-884.76	-6.55	-4.6
Total Debt / EBITDA	0.12	-0.04	-0.16	-0.88	-0.36
Net Debt / EBITDA	-7.09	2.3	0.48	0.09	0.63
Total Debt / (EBITDA - Capex)	0.12	-0.04	-0.16	-0.88	-0.36
Net Debt / (EBITDA - Capex)	-7.18	2.24	0.48	0.09	0.63
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	69.16K	-70.58	-90.71	1.57K	-39.28
Gross Profit, 1 Yr. Growth %	-292.94	-151.39	89.49	-66.06	0.6
EBITDA, 1 Yr. Growth %	-158.17	-309.66	61.03	-59.77	19.56
EBITA, 1 Yr. Growth %	-157.42	-313.03	60.79	-59.48	19.26
EBIT, 1 Yr. Growth %	-157.42	-313.03	60.79	-59.48	19.26
Earnings From Cont. Operations, 1 Yr. Growth %	-156.5	-319.01	56.82	-53.26	32.34
Net Income, 1 Yr. Growth %	-156.5	-319.01	56.82	-53.26	32.34
Normalized Net Income, 1 Yr. Growth %	-156.5	-319.01	56.82	-53.26	32.34
Diluted EPS Before Extra, 1 Yr. Growth %	-152.02	-318.8	56.71	-53.27	2.45
Accounts Receivable, 1 Yr. Growth %	-	-25.68	-	-	-
Net Property, Plant and Equip., 1 Yr. Growth %	93.4	-4.06	-16.7	46.78	-44.11
Total Assets, 1 Yr. Growth %	27.67	-31.52	-45.26	-23.1	3.37
Tangible Book Value, 1 Yr. Growth %	34.04	-31.68	-71.76	-120.65	13.47
Common Equity, 1 Yr. Growth %	14.83	-27.2	-60.2	-71.81	-5.87
Cash From Operations, 1 Yr. Growth %	-244.19	-210.86	15.59	-60.21	-15.81
Capital Expenditures, 1 Yr. Growth %	79.7	306.21	-89.81	-32.08	-
Levered Free Cash Flow, 1 Yr. Growth %	-226.02	-248.61	-3.46	-61.23	-52.8
Unlevered Free Cash Flow, 1 Yr. Growth %	-226.71	-247.85	-3.41	-67.74	-78.1
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.26K	1.33K	-83.47	24.41	218.12
Gross Profit, 2 Yr. CAGR %	33.44	-0.43	-1.32	-19.8	-41.56
EBITDA, 2 Yr. CAGR %	-25.22	10.44	83.74	-19.52	-30.65
EBITA, 2 Yr. CAGR %	-25.68	10.6	85.08	-19.29	-30.49
EBIT, 2 Yr. CAGR %	-25.68	10.6	85.08	-19.29	-30.49
Earnings From Cont. Operations, 2 Yr. CAGR %	-26.6	11.24	85.32	-14.38	-21.35
Net Income, 2 Yr. CAGR %	-26.6	11.24	85.32	-14.38	-21.35
Normalized Net Income, 2 Yr. CAGR %	-26.35	11.24	85.32	-14.38	-21.35
Diluted EPS Before Extra, 2 Yr. CAGR %	-35.01	6.69	85.17	-14.41	-30.81
Accounts Receivable, 2 Yr. CAGR %	-	-	-	-	-
Net Property, Plant and Equip., 2 Yr. CAGR %	18.77	36.22	-10.61	10.57	-9.43
Total Assets, 2 Yr. CAGR %	50.69	-6.5	-38.77	-35.12	-10.84
Tangible Book Value, 2 Yr. CAGR %	88.65	-4.3	-56.07	-75.85	-51.6
Common Equity, 2 Yr. CAGR %	48.22	-8.57	-46.17	-66.5	-48.49
Cash From Operations, 2 Yr. CAGR %	18.77	26.43	13.2	-32.18	-42.12
Capital Expenditures, 2 Yr. CAGR %	127.33	170.18	-35.67	-73.7	-
Levered Free Cash Flow, 2 Yr. CAGR %	16.11	36.85	19.78	-38.82	-57.22
Unlevered Free Cash Flow, 2 Yr. CAGR %	16.5	36.88	19.51	-44.17	-73.42
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	919.65	447.75	166.5	-23.06	-2.04
Gross Profit, 3 Yr. CAGR %	32.59	-2.92	23.39	-30.86	-13.5
EBITDA, 3 Yr. CAGR %	-10.01	5.44	25.23	10.74	-8.17
EBITA, 3 Yr. CAGR %	-10.43	5.57	25.29	11.54	-8.07
EBIT, 3 Yr. CAGR %	-10.43	5.57	25.29	11.54	-8.07
Earnings From Cont. Operations, 3 Yr. CAGR %	-11.26	5.67	24.73	17.09	-1.01
Net Income, 3 Yr. CAGR %	-11.26	5.67	24.73	17.09	-1.01
Normalized Net Income, 3 Yr. CAGR %	-10.96	5.91	24.73	17.09	-1.01
Diluted EPS Before Extra, 3 Yr. CAGR %	-19.79	-2.6	21.27	17.03	-9.13
Net Property, Plant and Equip., 3 Yr. CAGR %	91.06	10.61	15.62	5.46	-11.92
Total Assets, 3 Yr. CAGR %	28.07	15.86	-21.78	-33.94	-24.22
Tangible Book Value, 3 Yr. CAGR %	39.96	34.47	-36.29	-65.85	-59.55
Common Equity, 3 Yr. CAGR %	23.42	16.95	-30.7	-56.61	-52.73
Cash From Operations, 3 Yr. CAGR %	22.03	16.07	22.71	-20.11	-27.11
Capital Expenditures, 3 Yr. CAGR %	-12.37	175.86	-9.4	-34.5	-
Levered Free Cash Flow, 3 Yr. CAGR %	16.27	26.07	21.82	-17.76	-43.89
Unlevered Free Cash Flow, 3 Yr. CAGR %	16.51	26.13	21.86	-22.76	-59.13
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	131.46	254.63	96.06	202.76	186.06
Gross Profit, 5 Yr. CAGR %	31.45	10.05	17.81	-10.06	-8.49
EBITDA, 5 Yr. CAGR %	3.02	15.16	19.73	-5.36	-1.13
EBITA, 5 Yr. CAGR %	2.68	15.17	19.74	-5.18	-1.01
EBIT, 5 Yr. CAGR %	2.68	15.17	19.74	-5.18	-1.01
Earnings From Cont. Operations, 5 Yr. CAGR %	3.93	15.06	19.14	-2.86	3.72
Net Income, 5 Yr. CAGR %	3.93	15.06	19.14	-2.86	3.72
Normalized Net Income, 5 Yr. CAGR %	2.36	14.63	19.38	-2.73	3.72
Diluted EPS Before Extra, 5 Yr. CAGR %	-10.64	5.61	12.09	-7.51	-3.1
Accounts Receivable, 5 Yr. CAGR %	-	180.89	-	-	-
Net Property, Plant and Equip., 5 Yr. CAGR %	66.68	75.73	41	10.59	4.86
Total Assets, 5 Yr. CAGR %	33.1	14.7	-4.67	-8.12	-17.57
Tangible Book Value, 5 Yr. CAGR %	76.38	27.63	-11.96	-32.34	-42.92
Common Equity, 5 Yr. CAGR %	30.91	13.41	-11.44	-29.07	-38.46
Cash From Operations, 5 Yr. CAGR %	25.81	19.82	18.42	-6.38	-9.15
Capital Expenditures, 5 Yr. CAGR %	26.45	66.91	-22.56	7.75	-
Levered Free Cash Flow, 5 Yr. CAGR %	21.83	22.47	17.66	-5.59	-19.84
Unlevered Free Cash Flow, 5 Yr. CAGR %	21.92	23.26	17.7	-8.96	-33.72